Freshpet (FRPT) 10-Q10 Dec 142014 Q3 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
Document and Entity Information	Sep. 30, 2014	Dec. 08, 2014
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Entity Registrant Name	'FRESHPET, INC.	'
Entity Central Index Key	'0001611647	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Non-accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	33,467,676

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2014	Dec. 31, 2013
CURRENT ASSETS:	'	'
Cash and equivalents	$1,758,202	$2,444,754
Accounts receivable, less allowance for doubtful accounts of $314,543 on September 30, 2014 and $243,777 on December 31, 2013	4,230,006	3,497,596
Inventories, net	6,865,621	5,512,225
Deferred offering costs	1,610,130	'
Prepaid expenses and other current assets	214,802	173,786
Total Current Assets	14,678,761	11,628,361
Property, plant and equipment, net	55,850,447	48,764,032
Deposits on equipment	3,698,954	1,183,209
Other assets	1,028,744	1,041,622
Total Assets	75,256,906	62,617,224
CURRENT LIABILITIES:	'	'
Accounts payable	10,658,050	6,286,720
Accrued expenses	3,624,191	1,907,481
Total Current Liabilities	14,282,241	8,194,201
OTHER LIABILITIES:	'	'
Long-term debt	1,153,850	1,112,312
Notes payable	84,500,000	75,000,000
Accrued fees on debt guarantee	17,601,407	7,140,136
Accrued interest on long term debt	828,448	667,110
Other Liabilities	369,564	369,564
Total Liabilities	118,735,510	92,483,323
COMMITMENTS AND CONTINGENCIES	'	'
STOCKHOLDERSâ€™ EQUITY (DEFICIT):	'	'
Common stockâ€”voting, $0.001 par value, 60,000,000 and 54,000,000 shares authorized, 10,421,419 issued and outstanding on September 30, 2014 and December 31, 2013	10,421	10,421
Additional paid-in capital	7,434,249	16,450,175
Accumulated deficit	-168,410,901	-147,518,634
Total Stockholdersâ€™ Deficit	-160,966,231	-131,058,038
Total Liabilities and Stockholdersâ€™ Deficit	75,256,906	62,617,224
Redeemable Preferred Stock Series B	'	'
REDEEMABLE PREFERRED STOCK	'	'
Preferred stock	34,323,206	30,728,450
Redeemable Preferred Stock Series C	'	'
REDEEMABLE PREFERRED STOCK	'	'
Preferred stock	$83,164,421	$70,463,489

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Allowance for doubtful accounts	$314,543	$243,777
Redeemable preferred stock, shares authorized	20,250,000	'
Redeemable preferred stock, shares outstanding	12,598,066	'
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	60,000,000	54,000,000
Common stock, shares issued	10,421,419	10,421,419
Common stock, shares outstanding	10,421,419	10,421,419
Redeemable Preferred Stock Series B	'	'
Redeemable preferred stock, par value	$0.00	$0.00
Redeemable preferred stock, shares authorized	250,000	250,000
Redeemable preferred stock, shares issued	112,160	112,160
Redeemable preferred stock, shares outstanding	112,160	112,160
Redeemable Preferred Stock Series C	'	'
Redeemable preferred stock, par value	$0.00	$0.00
Redeemable preferred stock, shares authorized	20,000,000	15,000,000
Redeemable preferred stock, shares issued	12,485,906	11,238,098
Redeemable preferred stock, shares outstanding	12,485,906	11,238,098

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Statement [Abstract]	'	'	'	'
NET SALES	$22,519,672	$16,698,903	$62,255,907	$45,430,454
COST OF GOODS SOLD	11,645,685	9,421,530	32,015,950	24,655,694
GROSS PROFIT	10,873,987	7,277,373	30,239,957	20,774,760
SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES	12,212,406	11,459,693	37,208,200	31,310,296
LOSS FROM OPERATIONS	-1,338,419	-4,182,320	-6,968,243	-10,535,536
OTHER EXPENSES:	'	'	'	'
Other Expenses	-108,872	-63,764	-193,948	-93,099
Fees on Debt Guarantee	-6,816,055	-1,262,857	-10,461,271	-3,297,268
Interest expense	-1,211,895	-978,820	-3,244,805	-2,518,393
Other Expenses, Total	-8,136,822	-2,305,441	-13,900,024	-5,908,760
LOSS BEFORE INCOME TAXES	-9,475,241	-6,487,761	-20,868,267	-16,444,296
INCOME TAX EXPENSE	8,000	7,882	24,000	23,644
NET LOSS	-9,483,241	-6,495,643	-20,892,267	-16,467,940
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	($12,380,255)	($8,647,369)	($30,636,971)	($22,762,747)
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	'	'	'	'
-BASIC	($1.19)	($0.83)	($2.94)	($2.19)
-DILUTED	($1.19)	($0.83)	($2.94)	($2.19)
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING USED IN COMPUTING NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	'	'	'	'
-BASIC	10,421,419	10,413,467	10,421,419	10,413,467
-DILUTED	10,421,419	10,413,467	10,421,419	10,413,467

CONSOLIDATED_STATEMENT_OF_CASH

CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)	9 Months Ended
CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)	Sep. 30, 2014	Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:	'	'
Net loss	($20,892,267)	($16,467,940)
Adjustments to reconcile net loss to net cash flows from operating activities:	'	'
Provision for losses on accounts receivable	220,728	90,327
Loss on disposal of equipment and deposits on equipment	146,837	42,762
Fees on debt guarantee	10,461,271	3,297,268
Share-based compensation	728,778	731,467
Change in reserve for inventory obsolescence	-95,168	-7,491
Depreciation and amortization	4,744,857	3,290,221
Amortization of loan discount and deferred financing costs	189,071	140,845
Changes in operating assets and liabilities:	'	'
Accounts receivable	-953,138	186,617
Inventories	-1,258,228	-1,449,471
Prepaid expenses and other current assets	-41,016	-9,666
Other assets and deferred offering costs	-1,683,024	-50,001
Accounts payable	3,069,084	1,183,199
Accrued expenses and accrued interest on long-term debt	1,878,048	326,518
Net cash flows used in operating activities	-3,484,167	-8,695,345
CASH FLOWS FROM INVESTING ACTIVITIES:	'	'
Acquisitions of property, plant and equipment, software and deposits on equipment	-13,415,412	-22,029,885
Proceeds from sale of equipment	162,043	'
Net cash flows used in investing activities	-13,253,369	-22,029,885
CASH FLOWS FROM FINANCING ACTIVITIES:	'	'
Borrowings on notes payable	9,500,000	31,000,000
Financing fees paid in connection with note payable	'	-319,314
Proceeds from issuance of preferred stockâ€”Series C	6,550,984	'
Net cash flows from financing activities	16,050,984	30,680,686
NET CHANGE IN CASH AND EQUIVALENTS	-686,552	-44,544
CASH AND EQUIVALENTS, BEGINNING OF YEAR	2,444,754	1,633,249
CASH AND EQUIVALENTS, END OF PERIOD	1,758,202	1,588,705
SUPPLEMENTAL CASH FLOW INFORMATION:	'	'
Interest paid	2,925,699	2,367,099
NON-CASH FINANCING ACTIVITY:	'	'
Preferred stock dividend accretion	$9,744,704	$6,294,806

Nature_of_the_Business_and_Sum

Nature of the Business and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Nature of the Business and Summary of Significant Accounting Policies	'

	Note 1 – Nature of the Business and Summary of Significant Accounting Policies:
	Nature of the Business – Freshpet Inc. (hereafter referred to as “Freshpet” or the “Company”), a Delaware corporation, manufactures and markets natural fresh, refrigerated meals and treats for dogs and cats. The Company’s products are distributed throughout the United States and Canada into major retail classes including Grocery and Mass (which includes club) as well as Pet Specialty and Natural retail.
	Principles of Consolidation – The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”). The financial statements include the accounts of the Company and its wholly-owned subsidiary, Professor Connor’s Canada Inc. (“PCCI”). All significant intercompany accounts and transactions have been eliminated in consolidation.
	Basis of Presentation - The accompanying consolidated balance sheet as of September 30, 2014, statements of operations and comprehensive loss for the three and nine months ended September 30, 2014 and 2013, and statements of cash flows for the nine months ended September 30, 2014 and 2013 are unaudited. The interim unaudited financial statements have been prepared on the same basis as the annual audited financial statements and in accordance with the rules and regulations of the United States Securities and Exchange Commission. In the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of September 30, 2014, the results of its operations for the three and nine months ended September 30, 2014 and 2013, and its cash flows for the nine months ended September 30, 2014 and 2013. The financial data and other information disclosed in these notes related to the three and nine months ended September 30, 2014 and 2013 are unaudited. The results for three and nine months ended September 30, 2014 are not necessarily indicative of results to be expected for the year ending December 31, 2014, any other interim periods, or any future year or period.
	These consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2013, included in our prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the “Securities Act”) on November 10, 2014 (“Prospectus”).
	Estimates and Uncertainties - The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results, as determined at a later date, could differ from those estimates.
	Deferred Offering Cost - Deferred offering costs, which primarily consist of direct incremental legal and accounting fees relating to the initial public offering (“IPO”) of the Company’s common stock are capitalized. The deferred offering costs will be offset against IPO proceeds upon the consummation of the offering. We closed our IPO on November 13, 2014.
	Fair value of Financial Instruments - Financial Accounting Standards Board (‘‘FASB’’) guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).
	The three levels of the fair value hierarchy are as follows:
	·	Level 1 — Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities.
	·	Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active). Level 2 includes financial instruments that are valued using models or other valuation methodologies.
	·	Level 3 — Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when their fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable.
	The carrying amounts reported in the balance sheets for other receivables, accounts payable and accrued expenses approximate their fair value based on the short-term maturity of these instruments.

Recently_Issued_Accounting_Sta

Recently Issued Accounting Standards	9 Months Ended
Recently Issued Accounting Standards	Sep. 30, 2014
Accounting Policies [Abstract]	'
Recently Issued Accounting Standards	'
	Note 2 – Recently Issued Accounting Standards
	In April 2014, the FASB issued ASU 2014-08, “Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity,” (“ASU 2014-08”). Under ASU 2014-08, only disposals representing a strategic shift in operations that have a major effect on the Company’s operations and financial results should be presented as discontinued operations. Additionally, ASU 2014-08 requires expanded disclosures about discontinued operations that will provide financial statement users with more information about the assets, liabilities, income, and expenses of discontinued operations. The amendments in ASU 2014-08 are effective for fiscal years, and interim periods within those years, beginning after December 15, 2014. However, ASU 2014-08 should not be applied to a component that is classified as held for sale before the effective date even if the component is disposed of after the effective date. Early adoption is permitted, but only for disposals (or classifications as held for sale) that have not been reported in financial statements previously issued. The effects of ASU 2014-08 will depend on any future disposals by the Company.
	On May 28, 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard is effective for the Company on January 1, 2017. Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.

Inventories

Inventories	9 Months Ended
Inventories	Sep. 30, 2014
Inventory Disclosure [Abstract]	'
Inventories	'
	Note 3 – Inventories:
	Inventories are summarized as follows:

		September 30,			December 31,
		2014			2013
	Raw materials	$	2,065,744		$	1,431,422
	Packaging components material		1,275,459			805,424
	Finished goods		3,613,578			3,459,707
			6,954,781			5,696,553
	Reserve for obsolescence		(89,160	)		(184,328	)
		$	6,865,621		$	5,512,225

Property_Plant_and_Equipment

Property, Plant and Equipment	9 Months Ended
Property, Plant and Equipment	Sep. 30, 2014
Property Plant And Equipment [Abstract]	'
Property, Plant and Equipment	'
	Note 4 – Property, Plant and Equipment:
	Property, plant and equipment, net are summarized as follows:

		September 30,			December 31,
		2014			2013
	Refrigeration equipment	$	45,539,675		$	35,649,423
	Machinery and equipment		19,646,417			20,767,207
	Building and improvements		9,984,442			9,892,291
	Furniture and office equipment		1,794,859			1,727,248
	Leasehold improvements		627,962			1,474,741
	Construction in progress		1,003,309			143,274
	Automotive equipment		314,885			313,930
			78,911,549			69,968,114
	Less: Accumulated depreciation and amortization		(23,061,102	)		(21,204,082	)
		$	55,850,447		$	48,764,032
	Depreciation expense related to property, plant and equipment totaled $1,601,311 and $4,699,405 for the three and nine months ended September 30, 2014, respectively; of which $609,666 and $1,841,150 was recorded to cost of goods sold for the three and nine months ended September 30, 2014, respectively, with the remainder of depreciation and amortization expense recorded to selling, general and administrative expense. Depreciation expense related to property, plant and equipment totaled approximately $1,369,470 and $3,273,550 for three and nine months ended September 30, 2013, respectively; of which $338,222 and $697,841 was recorded to cost of goods sold for the three and nine months ended September 30, 2013, respectively, with the remainder of depreciation and amortization expense recorded to selling, general and administrative expense.
	During the three months ended March 31, 2014, the Company completed a project to analyze the estimated future years of service on its existing refrigeration equipment. Based on this analysis, the Company estimates that the useful life of its refrigeration equipment increased from 6 to 9 years. The Company will apply this change in estimate prospectively, which will reduce depreciation by approximately $1.8 million and $2.0 million for the full year 2014 and 2015, respectively. The useful life of the other classes of property, plant and equipment remains unchanged.

Accrued_Expenses

Accrued Expenses	9 Months Ended
Accrued Expenses	Sep. 30, 2014
Payables And Accruals [Abstract]	'
Accrued Expenses	'
	Note 5 – Accrued Expenses:
	Accrued expenses are summarized as follows:

		September 30,		December 31,
		2014		2013
	Accrued payroll and bonuses	$	1,213,494	$	1,131,880
	Accrued IPO cost		830,000		—
	Other accrued expenses		673,261		259,028
	Accrued interest		464,832		307,064
	Accrued Marketing		357,970		—
	Accrued Freight		84,634		166,472
	Accrued Maintenance		—		43,037
		$	3,624,191	$	1,907,481

Debt

Debt	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Debt	'
	Note 6 – Debt
	Our total debt outstanding consisted of the amounts set forth on the following table:

		September 30,		December 31,
		2014		2013
	$1,500,000 10% Note	$	1,153,850	$	1,112,312
	$22,000,000 Revolving Note Payable		22,000,000		15,000,000
	$62,500,000 Revolving Note Payable		62,500,000		60,000,000
		$	85,653,850	$	76,112,312
	a. $1,500,000 10% Note
	The $1,500,000 10% Note consists of $1,500,000 of notes issued to stockholders which accrue interest compounded annually at a rate of 10%. These notes and all accrued interest are due on December 23, 2020.
	In connection with the issuance of these notes in February 2010, for every $16.39 that was borrowed with the notes, 1 share of common stock was issued to the lender. As a result, 91,528 shares of common stock were issued and fair value of the stock at issuance, $6.56 per share, was recorded as a discount to the debt. The unamortized discount equaled $346,150 and $387,688 as of September 30, 2014 and December 31, 2013, respectively. The amortization expense of $13,846 and $41,538 for the three and nine months ended September 30, 2014, respectively, is recorded within interest expense in the statement of operations and comprehensive loss. The accrued interest totaled $828,448 and $667,110 as of September 30, 2014 and December 31, 2013, respectively. See note 13 for further detail.
	b. $22,000,000 Revolving Note Payable
	During September 2014, the revolving note payable agreement was amended to increase the maximum revolver amount up to $22,000,000 through and including November 30, 2014, and from then on after, the maximum revolver amount will be $20,000,000. The revolving note payable matures on October 31, 2015. The borrowings bear interest at either a LIBOR Rate plus 8% margin or a Base Rate plus 6%, depending on the election of the Company. Base Rate is defined as the rate of interest publicly quoted by The Wall Street Journal as the “base rate on corporate loans posted by at least 75% of the nation’s 30 largest banks.” If the Company elects to utilize the LIBOR Rate, it then elects to use a 1, 2, or 3 month LIBOR Rate with the interest payable upon the last day of the interest period applicable to the Company’s LIBOR rate election. Interest for the Base Rate loan is payable monthly with the balance of any outstanding advances due at maturity. An unused line of credit fee of 1%, payable monthly, is charged for any portion of the line that is not used, unless at least $3 million is kept on deposit with the bank. The Company has not kept a $3 million deposit with the bank.
	The loan is collateralized by substantially all of the Company’s assets. The loan agreement provides for the maintenance of various financial covenants. The Company is currently in compliance with these requirements. Borrowings on this revolving note payable totaled $22,000,000 at September 30, 2014 and $15,000,000 at December 31, 2013, as this revolving note payable was amended in March 2014 to increase the borrowing availability to $20,000,000, and in September 2014 to increase the borrowing availability to $22,00,000. The recorded carrying values of our debt balances approximate fair value given our debt is at variable rates tied to market indicators. See note 13 for further detail.
	c. $62,500,000 Revolving Note Payable
	The Company entered into a $62,500,000 revolving line of credit agreement with a maturity date of May 1, 2016. Subject to certain conditions, the maturity date may be extended until May 1, 2017 upon delivery of legal opinions stating that the majority stockholder has the right to call capital up through May 1, 2017. The borrowings bear interest at either a LIBOR Rate (LIBOR Adjusted Rate, plus 3.25%) or a Base Rate (Base Rate plus 2.25%). Base rate is defined as the greater of the Prime Rate on the date of the borrowing and the Federal Funds Effective Rate plus 0.5%. Interest on Base Rate Loans are payable monthly, LIBOR Rate loans are payable at the end of the selected interest rate. This revolving note payable is subordinated to the $22,000,000 note payable except for the first mortgage on the Bethlehem, PA property. The loan agreement provides for the maintenance of certain financial covenants. The Company is currently in compliance with these requirements. Borrowings on this revolving note payable totaled $62,500,000 as of September 30, 2014 and $60,000,000 at December 31, 2013. See note 13 for further detail.
	In connection with this note, the Company entered into a Fee and Reimbursement Agreement with certain stockholders who were also guarantors of the note. See note 8 for further detail.

Redeemable_Preferred_Stock

Redeemable Preferred Stock

9 Months Ended

Sep. 30, 2014

Temporary Equity Disclosure [Abstract]

Redeemable Preferred Stock

Note 7 – Redeemable Preferred Stock:

The redeemable preferred stock at September 30, 2014 consists of the following:

Series

Proceeds, Net

Authorized

Issued and

of Issuance

Outstanding

Costs

Preferred Stock Series B

250,000

112,160

11,159,992

Preferred Stock Series C

20,000,000

12,485,906

64,341,559

20,250,000

12,598,066

75,501,551

The Company issued an additional 1,247,808 shares of Preferred Stock Series C at $5.25 a share during the nine months ended September 30, 2014, with no shares issued during the three months ended September 30, 2014.

The dividends accrued during the three months ended September 30, 2014 and 2013 for the Preferred Stock Series B was $1,242,625 and $1,074,685, respectively. The dividends accrued during the nine months ended September 30, 2014 and 2013 for the Preferred Stock Series B was $3,594,756 and $3,099,191, respectively. The total cumulative dividends accrued as of September 30, 2014 was $23,163,214.

The dividends accrued during the three months ended September 30, 2014 and 2013 for the Preferred Stock Series C was $1,654,389 and $1,080,000, respectively. The dividends accrued during the nine months ended September 30, 2014 and 2013 for the Preferred Stock Series C was $6,149,948 and $3,240,000, respectively. The total cumulative dividends accrued as of September 30, 2014 was $18,822,873.

See note 13 for further detail.

Guarantee_Agreement

Guarantee Agreement	9 Months Ended
Guarantee Agreement	Sep. 30, 2014
Guarantees [Abstract]	'
Guarantee Agreement	'
	Note 8 – Guarantee Agreement:
	In connection with the $62,500,000 revolving note payable (see Note 6), the Company entered into a Fee and Reimbursement Agreement with certain stockholders who were also guarantors of the note. That agreement stipulated that the Company will pay each guarantor a contingent fee equal to 10% per annum of the amount that each guarantor has committed to guarantee. The payment will be made in the form of newly issued shares of Preferred Stock Series C at the price of $5.25 per share. The fee accrues only from and after the date that that the Guarantor enters into the Guarantee, and if at any time any Guarantor’s obligation is terminated in full or in part, the Fee shall continue to accrue only with respect to the amount, if any of such Guarantor’s remaining commitment under the Credit Agreement. The fee is contingent in that it will become due and payable only if all principal and interest under the credit agreement has been repaid and upon a Change of Control. A Change of Control is defined as any sale, merger, consolidation, share exchange, business combination, equity issuance, or other transaction or series of related transactions, specifically excluding public offerings, which result in the stockholders immediately prior to the transaction(s) owning collectively less than 50% of the voting control immediately following the transaction(s); or (ii) any sale, lease, exchange, transfer, or other disposition of substantially all of the assets, taken as a whole, in a single transaction or series of transactions, excluding sales in the ordinary course of business, sale/leaseback and corporate restructuring transactions.
	The Guarantee is a financial instrument recognized as a liability by the Company and recorded at fair value at issuance. The instrument is adjusted to its then fair value at each reporting period with changes in fair value recorded in the consolidated statement of operations and comprehensive loss. As of September 30, 2014, the Company measured the fair value of the outstanding guarantee fee using an option pricing method with several possible distribution outcomes depending on the timing and kind of liquidity event. Expected volatility is estimated utilizing the historical volatility of similar companies. The risk-free interest rates are based on the U.S. Treasury yield for a period consistent with the expected contractual life. The following assumptions were utilized:

		September 30,			December 31,
		2014			2013
	Expected volatility		26	%		17	%
	Remaining contractual life (in years)		0.8			1.5
	Risk-free interest rate		0.36	%		0.2	%
	Expected dividend yield		0	%		0	%
	The Company categorized the guarantee fee as a Level 3 financial liability since there is no market activity for the underlying Preferred Stock Series C.
	The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities:

	Balance at December 31, 2013	$	7,140,136
	Adjustment to fair value		10,461,271
	Balance at September 30, 2014	$	17,601,407

Equity_Incentive_Plans

Equity Incentive Plans	9 Months Ended
Equity Incentive Plans	Sep. 30, 2014
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]	'
Equity Incentive Plans	'
	Note 9 – Equity Incentive Plans:
	2006 Stock Plan—In December 2006, the Company approved the 2006 Stock Plan (the “2006 Plan”) under which options to purchase approximately 624,000 shares of the Company’s common stock were granted to employees and affiliates of the Company. These options vest over 5 years and approximately $11,394 and $34,182 was recorded as an expense for the three and nine months ended September 30, 2014, respectively. Approximately $14,657 and $43,971 was recorded as an expense for the three and nine months ended September 30, 2013. Certain option awards provide for accelerated vesting if there is a change in control (as defined in the 2006 Plan).
	2010 Stock Plan—In December 2010, the Company approved the 2010 Stock Plan (the “2010 Plan”) under which options to purchase approximately 2,146,320 shares of the Company’s common stock were granted to employees and affiliates of the Company (in 2012, the 2010 Plan was amended to allow for the granting of approximately 3,002,000 options to purchase shares of the Company’s common stock). These options are either time-based (vest over 4 years), performance-based (vest when performance targets are met, as defined in the stock option grant agreement), or vest at the occurrence of an exit event which is defined as a Change of Control in the Company (as defined in the stock option grant agreement) or an IPO registered under the Securities Act, as defined under the option grant agreement. Approximately $231,532 and $694,596 was recorded as an expense for the three and nine months ended September 30, 2014, respectively. Approximately $229,932 and $689,796 was recorded as an expense for the three and nine months ended September 30, 2013, respectively.
	During the nine months ended September 30, 2014 there were no grants or exercises of Service Based Options, Performance Based Options, and Exit Event Options plans.

Net_Loss_Attributable_to_Commo

Net Loss Attributable to Common Stockholders	9 Months Ended
Net Loss Attributable to Common Stockholders	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Net Loss Attributable to Common Stockholders	'
	Note 10 – Net Loss Attributable to Common Stockholders:
	Basic net loss per common share is calculated by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted net loss per common share is computed by giving effect to all potentially dilutive securities. Diluted net loss per common share is the same as basic net loss per common share, due to the fact that potentially dilutive securities would have an antidilutive effect as the Company incurred a net loss for the three and nine months ended September 30, 2014 and September 30, 2013.
	The potentially dilutive securities excluded from the determination of diluted loss per share, as their effect is antidilutive, are as follows:

		Three months ended						Nine months ended
		September 30,						September 30,
		2014			2013			2014			2013
	Convertible Preferred Series C (on an as-if converted basis)		9,234,560			7,607,303			8,967,953			7,607,303
	Service Period Stock Options		1,082,000			1,094,229			1,082,285			1,094,948
	Warrants		61,117			61,117			61,117			61,117
			10,377,677			8,762,649			10,111,355			8,763,368
	The computation of net income attributable to common stockholders is as follows:

		Three months ended						Nine months ended
		September,						September,
		2014			2013			2014			2013
	Net loss	$	(9,483,241	)	$	(6,495,643	)	$	(20,892,267	)	$	(16,467,940	)
	Preferred stock dividends on Series B and Series C		(2,897,014	)		(2,151,726	)		(9,744,704	)		(6,294,806	)
	Net loss attributable to common stockholders	$	(12,380,255	)	$	(8,647,369	)	$	(30,636,971	)	$	(22,762,747	)

Related_Party_Disclosures

Related Party Disclosures	9 Months Ended
Related Party Disclosures	Sep. 30, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure	'
	Note 11 – Related Party Transactions:
	Payments made to a stockholder for distribution services totaled $2,368,900 and $6,444,584 during the three and nine months ended September 30, 2014, respectively, and $1,624,854 and $4,559,834 during the three and nine months ended September 30, 2013, respectively. Payments of $1,440,360 and $3,920,827 for the three and nine months ended September 30, 2014, respectively and $1,178,217 and $3,354,558 for three and the nine months ended September 30, 2013, respectively, were made to stockholders for the purchase of raw materials. In addition there were payments of $19,841 and $163,471 for the three and nine months ended September 30, 2014, respectively and $148,663 and $583,178 for the three and nine months ended September 30, 2013, respectively, related to rent and associated utilities and maintenance to a stockholder who is also a landlord of one of our locations. The rent and associated utilities and maintenance cost were at market rates. None of the payments made above were to stockholders who are either an employee, board member, subsidiary, or affiliate of the Company.
	In connection with the $62,500,000 revolving note payable, certain stockholders are guarantors of the note. That agreement stipulated that the Company will pay each guarantor a contingent fee equal to 10% per annum of the amount that each guarantor has committed to guarantee. See Note 8 for further detail.

Concentrations

Concentrations	9 Months Ended
Concentrations	Sep. 30, 2014
Risks And Uncertainties [Abstract]	'
Concentrations	'
	Note 12 – Concentrations:
	Concentration of Credit Risk—The Company maintains its cash balances in financial institutions which are insured by the Federal Deposit Insurance Corporation up to $250,000 each. At times, such balances may be in excess of the FDIC insurance limit.
	Major Customers – For the three months ended September 30, 2014, and 2013, net sales to one of our distributors, which sells directly to three of our customers, accounted for 21% and 28% of our net sales, respectively. For the three months ended September 30, 2014 and September 30, 2013, no customer accounted for more than 10%of our net sales.
	For the nine months ended September 30, 2014 and 2013, net sales to one of our distributors which sells directly to three of our customers, accounted for 22% and 26% of our net sales, respectively. For the nine months ended September 30, 2014, no customer accounted for more than 10% of our net sales while for the same period in 2013 one customer accounted for 11% of our net sales.
	Major Suppliers—The Company purchased approximately 51% and 52% of its raw materials from three vendors during the three and nine months ended September 30, 2014, respectively, and approximately 57% and 58% of its raw materials from three vendors during the three and nine months ended September 30, 2013, respectively.
	The Company also purchased approximately 88% and 82% of its treats finished goods from two other vendors for the three and nine months ended September 30, 2014, respectively, and approximately 74% and 69% from three vendors for the three and nine months ended September 30, 2013, respectively.
	The Company purchased approximately 82% of its packaging material from our vendors during the three months ended September 30, 2014, and 75% of its packaging material from three vendors during the nine months ended September 30, 2014; and 78% and 63% of its packaging material from three vendors during the three and nine months ended September 30, 2013, respectively.
	For one of its raw material vendors, the Company has a purchase agreement whereby prices are fixed for one year periods. Prices adjust every April 1. The Company has the option to terminate the agreement at the beginning of any future one year period. The Company believes it could obtain similar pricing from another supplier, but a change could potentially cause production delays and additional costs.
	Net Sales By Class of Retail – The following table sets forth net sales by class of retail:

			Three months ended				Nine months ended
			September,				September,
			2014		2013		2014		2013
	Grocery and Mass (1)		$	16,671,443	$	13,135,742	$	46,522,636	$	35,610,217
	Pet Specialty, Natural and Other (2)			5,848,229		3,563,161		15,733,271		9,820,237
	Net Sales		$	22,519,672	$	16,698,903	$	62,255,907	$	45,430,454
	-1	Includes club retail class
	-2	Other sales represent less than 1% of net sales

Subsequent_Events

Subsequent Events	9 Months Ended
	Sep. 30, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	Note 13 – Subsequent Events:
	The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or unrecognized subsequent events that have required adjustment or disclosure in the financial statements other than as disclosed below:
	On October 3, 2014, the Company declared a stock split of 0.7396 shares for each share of common stock. Per the terms of the convertible Preferred Stock C, this stock split results in a proportional adjustment to the conversion ratio of each series of convertible preferred stock. Accordingly, all share and per share amounts for all periods presented in these consolidated financial statements and notes thereto, have been adjusted retroactively, where applicable, to reflect this stock split and adjustment of the preferred stock conversion ratio.
	On October 23 2014, the Company increased the borrowing availability on its revolving note payable from $22.0 million to $27.0 million and drew an additional $2.0 million to increase the borrowed principal to $24.0 million from $22.0 million at September 30, 2014.
	On October 23, 2014, the Company issued $2.0 million in aggregate principal amount of convertible notes to certain of its stockholders, which, beginning on December 7, 2014, accrue interest at a rate of 15%, compounded annually. The convertible notes were issued at 98% of par and are convertible into Preferred Stock Series C at a price of $5.25 per share, at the option of the holder, at any time after December 31, 2014 if the convertible notes remain outstanding. The convertible notes mature on November 1, 2017.
	IPO
	On November 13, 2014, the Company closed its IPO, in which it sold 11,979,167 shares of common stock, including 1,562,500 shares of common stock issued as a result of the full exercise of the underwriters’ option to purchase additional shares, at a price to the public of $15.00 per share. The aggregate amount of consideration for shares sold in the offering was $179.7 million. The Company raised approximately $164.1 million in net proceeds after deducting underwriting discounts and commissions of $12.6 million and estimated fees and expenses related to the offering.
	Immediately prior to the closing of the IPO, the Company converted outstanding fees under the guarantee into 2,477,713 shares of Preferred Stock Series C for a total of 14,963,658 shares of Preferred Stock Series C outstanding, and then converted all of its outstanding shares of Preferred Stock Series C into 11,067,090 shares of common stock.
	Immediately following the consummation of the IPO, the Company redeemed all outstanding shares of Preferred Stock Series B for $35 million in cash.

	Immediately prior to the consummation of the IPO, the Company filed its Amended and Restated Certificate of Incorporation with the Delaware Secretary of State and adopted its Amended and Restated Bylaws. The Amended and Restated Certificate of Incorporation authorizes 300,000,000 shares of capital stock, of which 200,000,000 shares, par value $0.001 per share, are common stock and 100,000,000 shares, par value $0.001 per share, are preferred stock.

	Immediately following the closing of the IPO on November 13, 2014, the Company made the following debt and Preferred Series B payments:

	·	Redeemed 112,160 outstanding Preferred Stock Series B shares, including cumulative dividends, for a cash payment of $35.0 million.
	·	Paid down the $62.5 Million Revolving Note Payable and accrued interest of $0.2 million.
	·	Paid down the outstanding $24.0 million on the $27.0 Million Revolver and accrued interest of $0.2 million.
	·	Paid down the $1.5 Million 10% Note and accrued interest of $0.9 million.

	On November 13, 2014, the Company entered into senior secured credit facilities with City National Bank comprising a 5-year $18.0 million term facility (the “Term Facility”), a 3-year $10.0 million revolving facility (the “Revolving Facility”) and a $12.0 million additional term loan commitment earmarked primarily for capital expenditures (the “Capex Commitments” and together with the Term Facility and Revolving Facility, the “Credit Facilities” and such loan agreement, the “Loan Agreement”). Upon closing the Credit Facilities, the Company had $18.0 million of aggregate principal amount outstanding under the Term Facility.
	Any drawn Capex Commitments will mature on the fifth anniversary of the execution of the Loan Agreement. Any undrawn Capex Commitments will expire on the second anniversary of the execution of the agreement. Under the terms of the Loan Agreement, the commitments for the Revolving Facility may be increased up to $20.0 million subject to certain conditions.
	Borrowings under the Credit Facilities will bear interest at variable rates depending on the Company’s election, either at a base rate or at LIBOR, in each case, plus an applicable margin. The initial applicable margin will be 3.75% for base rate loans and 4.75% for LIBOR loans. Thereafter, subject to the Company’s leverage ratio, the applicable base rate margin will vary from 2.75% and 3.75% and the applicable LIBOR rate margin will vary from 3.75% and 4.75%. In addition, the Company will also be required to pay customary fees and expenses for the Credit Facilities.

Nature_of_the_Business_and_Sum1

Nature of the Business and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Principles of Consolidation	'
	Principles of Consolidation – The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”). The financial statements include the accounts of the Company and its wholly-owned subsidiary, Professor Connor’s Canada Inc. (“PCCI”). All significant intercompany accounts and transactions have been eliminated in consolidation.
Basis of Presentation	'
	Basis of Presentation - The accompanying consolidated balance sheet as of September 30, 2014, statements of operations and comprehensive loss for the three and nine months ended September 30, 2014 and 2013, and statements of cash flows for the nine months ended September 30, 2014 and 2013 are unaudited. The interim unaudited financial statements have been prepared on the same basis as the annual audited financial statements and in accordance with the rules and regulations of the United States Securities and Exchange Commission. In the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of September 30, 2014, the results of its operations for the three and nine months ended September 30, 2014 and 2013, and its cash flows for the nine months ended September 30, 2014 and 2013. The financial data and other information disclosed in these notes related to the three and nine months ended September 30, 2014 and 2013 are unaudited. The results for three and nine months ended September 30, 2014 are not necessarily indicative of results to be expected for the year ending December 31, 2014, any other interim periods, or any future year or period.
	These consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2013, included in our prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the “Securities Act”) on November 10, 2014 (“Prospectus”).
Estimates and Uncertainties	'
	Estimates and Uncertainties - The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results, as determined at a later date, could differ from those estimates.
Deferred Offering Cost	'
	Deferred Offering Cost - Deferred offering costs, which primarily consist of direct incremental legal and accounting fees relating to the initial public offering (“IPO”) of the Company’s common stock are capitalized. The deferred offering costs will be offset against IPO proceeds upon the consummation of the offering. We closed our IPO on November 13, 2014.
Fair value of Financial Instruments	'
	Fair value of Financial Instruments - Financial Accounting Standards Board (‘‘FASB’’) guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).
	The three levels of the fair value hierarchy are as follows:
	·	Level 1 — Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities.
	·	Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active). Level 2 includes financial instruments that are valued using models or other valuation methodologies.
	·	Level 3 — Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when their fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable.
	The carrying amounts reported in the balance sheets for other receivables, accounts payable and accrued expenses approximate their fair value based on the short-term maturity of these instruments.
Recently Issued Accounting Standards	'
	In April 2014, the FASB issued ASU 2014-08, “Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity,” (“ASU 2014-08”). Under ASU 2014-08, only disposals representing a strategic shift in operations that have a major effect on the Company’s operations and financial results should be presented as discontinued operations. Additionally, ASU 2014-08 requires expanded disclosures about discontinued operations that will provide financial statement users with more information about the assets, liabilities, income, and expenses of discontinued operations. The amendments in ASU 2014-08 are effective for fiscal years, and interim periods within those years, beginning after December 15, 2014. However, ASU 2014-08 should not be applied to a component that is classified as held for sale before the effective date even if the component is disposed of after the effective date. Early adoption is permitted, but only for disposals (or classifications as held for sale) that have not been reported in financial statements previously issued. The effects of ASU 2014-08 will depend on any future disposals by the Company.
	On May 28, 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard is effective for the Company on January 1, 2017. Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.

Inventories_Tables

Inventories (Tables)	9 Months Ended
Inventories (Tables)	Sep. 30, 2014
Inventory Disclosure [Abstract]	'
Summary of Inventories	'
	Inventories are summarized as follows:

		September 30,			December 31,
		2014			2013
	Raw materials	$	2,065,744		$	1,431,422
	Packaging components material		1,275,459			805,424
	Finished goods		3,613,578			3,459,707
			6,954,781			5,696,553
	Reserve for obsolescence		(89,160	)		(184,328	)
		$	6,865,621		$	5,512,225

Property_Plant_and_Equipment_T

Property, Plant and Equipment (Tables)	9 Months Ended
Property, Plant and Equipment (Tables)	Sep. 30, 2014
Property Plant And Equipment [Abstract]	'
Summary of Property, Plant and Equipment, Net	'
	Property, plant and equipment, net are summarized as follows:

		September 30,			December 31,
		2014			2013
	Refrigeration equipment	$	45,539,675		$	35,649,423
	Machinery and equipment		19,646,417			20,767,207
	Building and improvements		9,984,442			9,892,291
	Furniture and office equipment		1,794,859			1,727,248
	Leasehold improvements		627,962			1,474,741
	Construction in progress		1,003,309			143,274
	Automotive equipment		314,885			313,930
			78,911,549			69,968,114
	Less: Accumulated depreciation and amortization		(23,061,102	)		(21,204,082	)
		$	55,850,447		$	48,764,032

Accrued_Expenses_Tables

Accrued Expenses (Tables)	9 Months Ended
Accrued Expenses (Tables)	Sep. 30, 2014
Payables And Accruals [Abstract]	'
Summary of Accrued Expenses	'
	Accrued expenses are summarized as follows:

		September 30,		December 31,
		2014		2013
	Accrued payroll and bonuses	$	1,213,494	$	1,131,880
	Accrued IPO cost		830,000		—
	Other accrued expenses		673,261		259,028
	Accrued interest		464,832		307,064
	Accrued Marketing		357,970		—
	Accrued Freight		84,634		166,472
	Accrued Maintenance		—		43,037
		$	3,624,191	$	1,907,481

Debt_Tables

Debt (Tables)	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Schedule of Outstanding Debt	'
	Our total debt outstanding consisted of the amounts set forth on the following table:

		September 30,		December 31,
		2014		2013
	$1,500,000 10% Note	$	1,153,850	$	1,112,312
	$22,000,000 Revolving Note Payable		22,000,000		15,000,000
	$62,500,000 Revolving Note Payable		62,500,000		60,000,000
		$	85,653,850	$	76,112,312

Redeemable_Preferred_Stock_Tab

Redeemable Preferred Stock (Tables)

9 Months Ended

Sep. 30, 2014

Temporary Equity Disclosure [Abstract]

Schedule of Redeemable Preferred Stock

The redeemable preferred stock at September 30, 2014 consists of the following:

Series

Proceeds, Net

Authorized

Issued and

of Issuance

Outstanding

Costs

Preferred Stock Series B

250,000

112,160

11,159,992

Preferred Stock Series C

20,000,000

12,485,906

64,341,559

20,250,000

12,598,066

75,501,551

Guarantee_Agreement_Tables

Guarantee Agreement (Tables)	9 Months Ended
Guarantee Agreement (Tables)	Sep. 30, 2014
Guarantees [Abstract]	'
Schedule of Risk-free Interest Rate Expected Contractual Life	'
	Expected volatility is estimated utilizing the historical volatility of similar companies. The risk-free interest rates are based on the U.S. Treasury yield for a period consistent with the expected contractual life. The following assumptions were utilized:
		September 30,			December 31,
		2014			2013
	Expected volatility		26	%		17	%
	Remaining contractual life (in years)		0.8			1.5
	Risk-free interest rate		0.36	%		0.2	%
	Expected dividend yield		0	%		0	%

Summary of Changes in Fair Value of Level 3 Financial Liabilities	'
	The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities:

	Balance at December 31, 2013	$	7,140,136
	Adjustment to fair value		10,461,271
	Balance at September 30, 2014	$	17,601,407

Net_Loss_Attributable_to_Commo1

Net Loss Attributable to Common Stockholders (Tables)	9 Months Ended
Net Loss Attributable to Common Stockholders (Tables)	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Schedule of Antidilutive Securities	'
	The potentially dilutive securities excluded from the determination of diluted loss per share, as their effect is antidilutive, are as follows:

		Three months ended						Nine months ended
		September 30,						September 30,
		2014			2013			2014			2013
	Convertible Preferred Series C (on an as-if converted basis)		9,234,560			7,607,303			8,967,953			7,607,303
	Service Period Stock Options		1,082,000			1,094,229			1,082,285			1,094,948
	Warrants		61,117			61,117			61,117			61,117
			10,377,677			8,762,649			10,111,355			8,763,368

Schedule of Net Income Attributable to Common Stockholders	'
	The computation of net income attributable to common stockholders is as follows:

		Three months ended						Nine months ended
		September,						September,
		2014			2013			2014			2013
	Net loss	$	(9,483,241	)	$	(6,495,643	)	$	(20,892,267	)	$	(16,467,940	)
	Preferred stock dividends on Series B and Series C		(2,897,014	)		(2,151,726	)		(9,744,704	)		(6,294,806	)
	Net loss attributable to common stockholders	$	(12,380,255	)	$	(8,647,369	)	$	(30,636,971	)	$	(22,762,747	)

Concentrations_Tables

Concentrations (Tables)	9 Months Ended
Concentrations (Tables)	Sep. 30, 2014
Risks And Uncertainties [Abstract]	'
Net Sales by Class of Retail	'
	The following table sets forth net sales by class of retail:

			Three months ended				Nine months ended
			September,				September,
			2014		2013		2014		2013
	Grocery and Mass (1)		$	16,671,443	$	13,135,742	$	46,522,636	$	35,610,217
	Pet Specialty, Natural and Other (2)			5,848,229		3,563,161		15,733,271		9,820,237
	Net Sales		$	22,519,672	$	16,698,903	$	62,255,907	$	45,430,454
	-1	Includes club retail class
	-2	Other sales represent less than 1% of net sales

Inventories_Summary_of_Invento

Inventories - Summary of Inventories (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Inventory Disclosure [Abstract]	'	'
Raw materials	$2,065,744	$1,431,422
Packaging components material	1,275,459	805,424
Finished goods	3,613,578	3,459,707
Inventory gross	6,954,781	5,696,553
Reserve for obsolescence	-89,160	-184,328
Inventory net	$6,865,621	$5,512,225

Property_Plant_and_Equipment_S

Property, Plant and Equipment - Summary of Property, Plant and Equipment, Net (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Property Plant And Equipment [Line Items]	'	'
Property, plant and equipment, gross	$78,911,549	$69,968,114
Less: Accumulated depreciation and amortization	-23,061,102	-21,204,082
Property, plant and equipment, net	55,850,447	48,764,032
Refrigeration Equipment	'	'
Property Plant And Equipment [Line Items]	'	'
Property, plant and equipment, gross	45,539,675	35,649,423
Machinery and Equipment	'	'
Property Plant And Equipment [Line Items]	'	'
Property, plant and equipment, gross	19,646,417	20,767,207
Building and Improvements	'	'
Property Plant And Equipment [Line Items]	'	'
Property, plant and equipment, gross	9,984,442	9,892,291
Furniture and Office Equipment	'	'
Property Plant And Equipment [Line Items]	'	'
Property, plant and equipment, gross	1,794,859	1,727,248
Leasehold Improvements	'	'
Property Plant And Equipment [Line Items]	'	'
Property, plant and equipment, gross	627,962	1,474,741
Construction in Progress	'	'
Property Plant And Equipment [Line Items]	'	'
Property, plant and equipment, gross	1,003,309	143,274
Automotive Equipment	'	'
Property Plant And Equipment [Line Items]	'	'
Property, plant and equipment, gross	$314,885	$313,930

Property_Plant_and_Equipment_A

Property, Plant and Equipment - Additional Information (Details) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended		3 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Mar. 31, 2014
					Refrigeration Equipment	Refrigeration Equipment	Minimum	Maximum
					Scenario, Forecast	Scenario, Forecast	Refrigeration Equipment	Refrigeration Equipment
Property Plant And Equipment [Line Items]	'	'	'	'	'	'	'	'
Depreciation expense	$1,601,311	$1,369,470	$4,699,405	$3,273,550	'	'	'	'
Cost of goods sold, depreciation	609,666	338,222	1,841,150	697,841	'	'	'	'
Estimated useful life	'	'	'	'	'	'	'6 years	'9 years
Reduction in refrigeration equipment	'	'	'	'	($2,000,000)	($1,800,000)	'	'

Accrued_Expenses_Summary_of_Ac

Accrued Expenses - Summary of Accrued Expenses (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Payables And Accruals [Abstract]	'	'
Accrued payroll and bonuses	$1,213,494	$1,131,880
Accrued IPO cost	830,000	'
Other accrued expenses	673,261	259,028
Accrued interest	464,832	307,064
Accrued Marketing	357,970	'
Accrued Freight	84,634	166,472
Accrued Maintenance	'	43,037
Accrued expenses	$3,624,191	$1,907,481

Debt_Schedule_of_Outstanding_D

Debt - Schedule of Outstanding Debt (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Debt Instrument [Line Items]	'	'
Long-term debt	$1,153,850	$1,112,312
Notes payable	84,500,000	75,000,000
Total long-term debt	85,653,850	76,112,312
$1,500,000 10% Note	'	'
Debt Instrument [Line Items]	'	'
Long-term debt	1,153,850	1,112,312
$22,000,000 Revolving Note Payable	'	'
Debt Instrument [Line Items]	'	'
Notes payable	22,000,000	15,000,000
$62,500,000 Revolving Note Payable	'	'
Debt Instrument [Line Items]	'	'
Notes payable	$62,500,000	$60,000,000

Debt_Schedule_of_Outstanding_D1

Debt - Schedule of Outstanding Debt (Parenthetical) (Details) (USD $)	Sep. 30, 2014
In Thousands, unless otherwise specified	Sep. 30, 2014
$1,500,000 10% Note	'
Debt Instrument [Line Items]	'
Debt instrument, face amount	$1,500
Debt instrument stated percentage	10.00%
$22,000,000 Revolving Note Payable	'
Debt Instrument [Line Items]	'
Debt instrument, face amount	22,000
$62,500,000 Revolving Note Payable	'
Debt Instrument [Line Items]	'
Debt instrument, face amount	$62,500

Debt_Additional_Information_De

Debt - Additional Information (Details) (USD $)

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Mar. 31, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

$1,500,000 10% Note

$22,000,000 Revolving Note Payable

$62,500,000 Revolving Note Payable

LIBOR Rate

Base Rate

LIBOR Rate

Base Rate

Debt Instrument [Line Items]

Debt instrument, face amount

$1,500,000

$22,000,000

$62,500,000

Debt instrument stated percentage

10.00%

Debt instrument, maturity date

23-Dec-20

Debt instrument, description

'In connection with the issuance of these notes in February 2010, for every $16.39 that was borrowed with the notes, 1 share of common stock was issued to the lender.

Debt note convertible conversion price

$16.39

Common stock, shares issued

10,421,419

91,528

Fair value of common stock issued

$6.56

Unamortized discount

346,150

387,688

Amortization expense included in interest expense

13,846

41,538

Accrued interest

828,448

667,110

828,448

667,110

Line of credit facility, maximum borrowing capacity

22,000,000

20,000,000

Line of credit, maturity date

31-Oct-15

1-May-16

Line of credit facility, borrowing capacity description

'During September 2014, the revolving note payable agreement was amended to increase the maximum revolver amount up to $22,000,000 through and including November 30, 2014, and from then on after, the maximum revolver amount will be $20,000,000.

Line of credit facility, interest rate

8.00%

6.00%

3.25%

2.25%

Line of credit facility, interest rate description

'Base Rate is defined as the rate of interest publicly quoted by The Wall Street Journal as the bbase rate on corporate loans posted by at least 75% of the nationbs 30 largest banks.b If the Company elects to utilize the LIBOR Rate, it then elects to use a 1, 2, or 3 month LIBOR Rate with the interest payable upon the last day of the interest period applicable to the Companybs LIBOR rate election. Interest for the Base Rate loan is payable monthly with the balance of any outstanding advances due at maturity.

'Base rate is defined as the greater of the Prime Rate on the date of the borrowing and the Federal Funds Effective Rate plus 0.5%. Interest on Base Rate Loans are payable monthly, LIBOR Rate loans are payable at the end of the selected interest rate.

Line of credit facility, unused capacity, commitment fee percentage

1.00%

Line of credit facility, collateral fees amount

3,000,000

Line of credit facility, collateral fees

'The Company has not kept a $3 million deposit with the bank.

Notes payable

$84,500,000

$75,000,000

$22,000,000

$15,000,000

$62,500,000

$60,000,000

Line of credit facility extended maturity date

1-May-17

Redeemable_Preferred_Stock_Sch

Redeemable Preferred Stock - Schedule of Redeemable Preferred Stock (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Temporary Equity [Line Items]	'
Redeemable preferred stock, shares authorized	20,250,000
Redeemable preferred stock, shares outstanding	12,598,066
Proceeds, Net of Issuance Costs	$75,501,551
Preferred Stock Series B	'
Temporary Equity [Line Items]	'
Redeemable preferred stock, shares authorized	250,000
Redeemable preferred stock, shares outstanding	112,160
Proceeds, Net of Issuance Costs	11,159,992
Preferred Stock Series C	'
Temporary Equity [Line Items]	'
Redeemable preferred stock, shares authorized	20,000,000
Redeemable preferred stock, shares outstanding	12,485,906
Proceeds, Net of Issuance Costs	$64,341,559

Redeemable_Preferred_Stock_Add

Redeemable Preferred Stock - Additional Information (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Redeemable Preferred Stock Series C	'	'	'	'
Temporary Equity [Line Items]	'	'	'	'
Preferred stock, shares issued	0	'	1,247,808	'
Preferred stock, shares issued price	$5.25	'	$5.25	'
Dividends accrued	$1,654,389	$1,080,000	$6,149,948	$3,240,000
Cumulative dividends accrued	18,822,873	'	18,822,873	'
Redeemable Preferred Stock Series B	'	'	'	'
Temporary Equity [Line Items]	'	'	'	'
Dividends accrued	1,242,625	1,074,685	3,594,756	3,099,191
Cumulative dividends accrued	$23,163,214	'	$23,163,214	'

Guarantee_Agreement_Additional

Guarantee Agreement - Additional Information (Details) (USD $)	9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Guarantee Obligations [Line Items]	'	'
Notes payable	$84,500	$75,000
Percentage of contingent fee	10.00%	'
Percent of voting control	50.00%	'
$62,500,000 Revolving Note Payable	'	'
Guarantee Obligations [Line Items]	'	'
Notes payable	$62,500	'
Redeemable Preferred Stock Series C	'	'
Guarantee Obligations [Line Items]	'	'
Preferred stock, shares issued price	$5.25	'

Guarantee_Agreement_Schedule_o

Guarantee Agreement - Schedule of Risk-free Interest Rate Expected Contractual Life (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Guarantees [Abstract]	'	'
Expected volatility	26.00%	17.00%
Remaining contractual life (in years)	'9 months 18 days	'1 year 6 months
Risk-free interest rate	0.36%	0.20%
Expected dividend yield	0.00%	0.00%

Guarantee_Agreement_Summary_of

Guarantee Agreement - Summary of Changes in Fair Value of Level 3 Financial Liabilities (Details) (Level 3, USD $)	9 Months Ended
	Sep. 30, 2014
Level 3	'
Guarantee Obligations [Line Items]	'
Beginning balance	$7,140,136
Adjustment to fair value	10,461,271
Ending balance	$17,601,407

Equity_Incentive_Plans_Additio

Equity Incentive Plans - Additional Information (Details) (USD $)	1 Months Ended	3 Months Ended		9 Months Ended		1 Months Ended	3 Months Ended		9 Months Ended
	Dec. 31, 2006	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2010	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2012
	2006 Stock Plan	2006 Stock Plan	2006 Stock Plan	2006 Stock Plan	2006 Stock Plan	2010 Stock Plan	2010 Stock Plan	2010 Stock Plan	2010 Stock Plan	2010 Stock Plan	2010 Stock Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Stock options, number of shares granted	624,000	'	'	'	'	2,146,320	'	'	0	'	'
Stock options vesting period	'5 years	'	'	'	'	'4 years	'	'	'	'	'
Stock option plan expense	'	$11,394	$14,657	$34,182	$43,971	'	$231,532	$229,932	$694,596	$689,796	'
Stock options, available for grant	'	'	'	'	'	'	'	'	'	'	3,002,000
Stock options, number of shares exercised	'	'	'	'	'	'	'	'	0	'	'

Net_Loss_Attributable_to_Commo2

Net Loss Attributable to Common Stockholders - Schedule of Antidilutive Securities (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive Securities	10,377,677	8,762,649	10,111,355	8,763,368
Convertible Preferred Series C	'	'	'	'
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive Securities	9,234,560	7,607,303	8,967,953	7,607,303
Service Period Stock Options	'	'	'	'
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive Securities	1,082,000	1,094,229	1,082,285	1,094,948
Warrants	'	'	'	'
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive Securities	61,117	61,117	61,117	61,117

Net_Loss_Attributable_to_Commo3

Net Loss Attributable to Common Stockholders - Schedule of Net Income Attributable to Common Stockholders (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Earnings Per Share Basic [Line Items]	'	'	'	'
Net loss	($9,483,241)	($6,495,643)	($20,892,267)	($16,467,940)
Net loss attributable to common stockholders	-12,380,255	-8,647,369	-30,636,971	-22,762,747
Series B and Series C Preferred Stock	'	'	'	'
Earnings Per Share Basic [Line Items]	'	'	'	'
Preferred stock dividends on Series B and Series C	($2,897,014)	($2,151,726)	($9,744,704)	($6,294,806)

Related_Party_Transactions_Add

Related Party Transactions - Additional Information (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Related Party Transaction [Line Items]	'	'	'	'
Revolving note payable	$22,000,000	'	$22,000,000	'
Percentage of contingent fee	'	'	10.00%	'
Revolving Credit	'	'	'	'
Related Party Transaction [Line Items]	'	'	'	'
Revolving note payable	62,500,000	'	62,500,000	'
Distribution Services	'	'	'	'
Related Party Transaction [Line Items]	'	'	'	'
Payments made to a stockholder for distribution services	2,368,900	1,624,854	6,444,584	4,559,834
Purchases of Raw Materials	'	'	'	'
Related Party Transaction [Line Items]	'	'	'	'
Payments made to a stockholder for distribution services	1,440,360	1,178,217	3,920,827	3,354,558
Rent and Associated Utilities and Maintenance	'	'	'	'
Related Party Transaction [Line Items]	'	'	'	'
Payments made to a stockholder for distribution services	$19,841	$148,663	$163,471	$583,178

Concentrations_Additional_Info

Concentrations - Additional Information (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
	Customer	Customer	Customer	Customer
Distributors Concentration Risk \| Sales Revenue Net	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration risk, percentage	21.00%	28.00%	22.00%	26.00%
Number of customers	3	3	3	3
Customer Concentration Risk \| Sales Revenue Net	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration risk, percentage	10.00%	10.00%	10.00%	11.00%
Number of customers	0	0	0	1
Supplier Concentration Risk \| Purchases of Raw Materials	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration risk, percentage	51.00%	57.00%	52.00%	58.00%
Number of vendors	3	3	3	3
Supplier Concentration Risk \| Finished Goods	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration risk, percentage	88.00%	74.00%	82.00%	69.00%
Number of vendors	2	3	2	3
Supplier Concentration Risk \| Packaging Materials	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration risk, percentage	82.00%	78.00%	75.00%	63.00%
Number of vendors	'	3	3	3
Maximum	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Cash, FDIC insured amount	250,000	'	250,000	'

Concentrations_Net_Sales_by_Cl

Concentrations - Net Sales by Class of Retail (Details) (USD $)	3 Months Ended				9 Months Ended
	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013
Concentration Risk [Line Items]	'		'		'		'
NET SALES	$22,519,672		$16,698,903		$62,255,907		$45,430,454
Grocery and Mass	'		'		'		'
Concentration Risk [Line Items]	'		'		'		'
NET SALES	16,671,443	[1]	13,135,742	[1]	46,522,636	[1]	35,610,217	[1]
Pet Specialty, Natural and Other	'		'		'		'
Concentration Risk [Line Items]	'		'		'		'
NET SALES	$5,848,229	[2]	$3,563,161	[2]	$15,733,271	[2]	$9,820,237	[2]

[1]	Includes club retail class
[2]	Other sales represent less than 1% of net sales

Concentrations_Net_Sales_by_Cl1

Concentrations - Net Sales by Class of Retail (Parenthetical) (Details) (Maximum)	9 Months Ended
	Sep. 30, 2014
Maximum	'
Concentration Risk [Line Items]	'
Percentage of other sales in net sales	1.00%

Subsequent_Events_Additional_I

Subsequent Events - Additional Information (Details) (USD $)

9 Months Ended

0 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Dec. 07, 2014

Sep. 30, 2014

Nov. 13, 2014

Oct. 23, 2014

Oct. 03, 2014

Nov. 13, 2014

Oct. 23, 2014

Nov. 13, 2014

Scenario, Forecast

$22,000,000 Revolving Note Payable

Revolving Credit

Subsequent Event

$1,500,000 10% Note

IPO

Redeemable Preferred Stock Series C

Redeemable Preferred Stock Series B

Revolving Credit

Term Facility

Capex Commitments

IPO

Base Rate

LIBOR Rate

Minimum

Maximum

Minimum

Maximum

Subsequent Event [Line Items]

Issue of shares for stock split

0.7396

Line of credit facility, maximum borrowing capacity

$22,000,000

$27,000,000

$10,000,000

Credit facility, increase in maximum borrowing capacity

2,000,000

Revolving note payable

22,000,000

62,500,000

24,000,000

Aggregate principle amount of convertible notes

2,000,000

Interest accrued on convertible notes

15.00%

Percentage of convertible notes issued

98.00%

Price per share of convertible preferred share

$5.25

Debt instrument, maturity date

1-Nov-17

Number of common stock sold

10,421,419

11,979,167

Number of shares purchased by underwriters

1,562,500

Common stock initial offering price during IPO

$15

Aggregate amount of consideration

179,700,000

Net proceeds from IPO

164,100,000

Underwriting discounts and commissions

12,600,000

Convertible Preferred Stock Shares Issued Upon Conversion

2,477,713

Number of preferred stock converted in to common stock

14,963,658

Debt Conversion Converted Instrument Shares Issued1

11,067,090

Redeemed outstanding shares value

35,000,000

Capital stock, authorized

300,000,000

Common stock, shares authorized

60,000,000

54,000,000

200,000,000

Common stock, par value

$0.00

Preferred stock, authorized

100,000,000

Preferred stock, par value

$0.00

Outstanding preferred stock redeemed

112,160

Cash payment of cumulative dividends

35,000,000

Payment of revolving note payable

62,500,000

Payment of accrued interest

2,925,699

2,367,099

200,000

900,000

200,000

Payment of line of credit

24,000,000

Payment of long term debt

1,500,000

Term loan expiration period

'5 years

Credit facilities , term

'3 years

Debt instrument, face amount

18,000,000

12,000,000

Credit facility, outstanding

18,000,000

Increase in credit facility

$20,000,000

Line of credit facility, interest rate

3.75%

2.75%

3.75%

4.75%

3.75%

4.75%